Skip to main content
Log in

Pembrolizumab

Graft versus host disease following an off-label pembrolizumab therapy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Boekstegers A-M, et al. Treatment of refractory pediatric acute lymphoblastic T cell leukaemia with anti-programmed cell death protein 1 (PD-1) antibody after allogeneic stem cell transplantation. Bone Marrow Transplantation 52 (Suppl. 1): 258-259, Jan 2017 [abstract] - Germany

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pembrolizumab. Reactions Weekly 1696, 300 (2018). https://doi.org/10.1007/s40278-018-44488-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44488-1

Navigation